Author

A. Cramer

Primary ORCID profile (0000-0003-2997-5066 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

A. CrameriD1 paper · Cincinnati Children's Hospital Medical Center

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Bruckner· 1 shared A. C. d. S. P. Andrade· 1 shared A. C. Ferreira· 1 shared A. Christiano· 1 shared A. E. Oro· 1 shared A. F. A. Figueiredo· 1 shared A. Pappalardo· 1 shared A. Rami· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Bruckner

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery

S. Hindi, M. Petrany, E. Greenfeld, L. Focke, A. Cramer, M. Whitt, V. Prasad, J. Chamberlain, B. Podbilewicz, D. Millay

This study shows that pseudotyping enveloped viruses with muscle fusogens enables targeted gene delivery to skeletal muscle in a mouse model of Duchenne muscular dystrophy.

bioRxiv · Mar 17, 2023Cell Biology

A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa

G. Neumayer, J. Torkelson, S. Li, K. McCarthy, H. Zhen, M. Vangipuram, J. Jackow, A. Rami, C. Hansen, Z. Guo, S. Gaddam, A. Pappalardo, L. Li, A. Cramer, K. Roy, , A. E. Oro

This paper develops a scalable, GMP-compatible cell therapy for Dystrophic Epidermolysis Bullosa using CRISPR-corrected iPS cells to generate functional skin grafts.

bioRxiv · Feb 28, 2023 · PreprintBioengineering

A suitable murine model for studying respiratory coronavirus infection and therapeutic countermeasures in BSL-2 laboratories

A. C. d. S. P. Andrade, G. H. Campolina-Silva, C. M. Queiroz-Junior, L. C. de Oliveira, L. d. S. B. Lacerda, J. C. Pimenta, F. R. O. de Souza, I. d. M. Chaves, I. B. Passos, D. C. Teixeira, P. G. Bittencourt-Silva, P. A. C. Valadao, L. Rossi-Oliveira, M. M. Antunes, A. F. A. Figueiredo, , Costa

This study evaluates a murine model using MHV-3 to mimic COVID-19 pathogenesis and tests TNF inhibition as a therapeutic strategy.

bioRxiv · May 28, 2021 · PreprintMicrobiology